These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32271882)

  • 21. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
    Cookson MR
    Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.
    Nguyen AP; Moore DJ
    Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caught in the act: LRRK2 in exosomes.
    Wang S; West AB
    Biochem Soc Trans; 2019 Apr; 47(2):663-670. PubMed ID: 30837321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells.
    Thirstrup K; Dächsel JC; Oppermann FS; Williamson DS; Smith GP; Fog K; Christensen KV
    Sci Rep; 2017 Aug; 7(1):10300. PubMed ID: 28860483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?
    Outeiro TF; Harvey K; Dominguez-Meijide A; Gerhardt E
    Biochem Soc Trans; 2019 Jun; 47(3):827-838. PubMed ID: 31085616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2.
    Huang X; Wu C; Park Y; Long X; Hoang QQ; Liao J
    FASEB J; 2019 Apr; 33(4):4814-4823. PubMed ID: 30592623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death.
    Yoon JH; Mo JS; Kim MY; Ann EJ; Ahn JS; Jo EH; Lee HJ; Lee YC; Seol W; Yarmoluk SM; Gasser T; Kahle PJ; Liu GH; Belmonte JCI; Park HS
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2356-2368. PubMed ID: 28888991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation.
    Kamikawaji S; Ito G; Sano T; Iwatsubo T
    Biochemistry; 2013 Sep; 52(35):6052-62. PubMed ID: 23924436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
    Shu Y; Ming J; Zhang P; Wang Q; Jiao F; Tian B
    PLoS One; 2016; 11(3):e0149739. PubMed ID: 26930193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
    Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
    Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites.
    Marte A; Russo I; Rebosio C; Valente P; Belluzzi E; Pischedda F; Montani C; Lavarello C; Petretto A; Fedele E; Baldelli P; Benfenati F; Piccoli G; Greggio E; Onofri F
    J Neurochem; 2019 Aug; 150(3):264-281. PubMed ID: 31148170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5.
    Shanley MR; Hawley D; Leung S; Zaidi NF; Dave R; Schlosser KA; Bandopadhyay R; Gerber SA; Liu M
    Biochemistry; 2015 Aug; 54(33):5198-208. PubMed ID: 26268594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?
    Taymans JM; Mutez E; Drouyer M; Sibran W; Chartier-Harlin MC
    Biochem Soc Trans; 2017 Feb; 45(1):207-212. PubMed ID: 28202674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.
    Gloeckner CJ; Boldt K; von Zweydorf F; Helm S; Wiesent L; Sarioglu H; Ueffing M
    J Proteome Res; 2010 Apr; 9(4):1738-45. PubMed ID: 20108944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2.
    Langston RG; Rudenko IN; Kumaran R; Hauser DN; Kaganovich A; Ponce LB; Mamais A; Ndukwe K; Dillman AA; Al-Saif AM; Beilina A; Cookson MR
    Neurochem Res; 2019 Jun; 44(6):1446-1459. PubMed ID: 30291536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease.
    Chen ZC; Zhang W; Chua LL; Chai C; Li R; Lin L; Cao Z; Angeles DC; Stanton LW; Peng JH; Zhou ZD; Lim KL; Zeng L; Tan EK
    Sci Signal; 2017 Jul; 10(488):. PubMed ID: 28720718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitro.
    Liu Z; West AB
    Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):274-280. PubMed ID: 27939437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.
    Liu SY; Wile DJ; Fu JF; Valerio J; Shahinfard E; McCormick S; Mabrouk R; Vafai N; McKenzie J; Neilson N; Perez-Soriano A; Arena JE; Cherkasova M; Chan P; Zhang J; Zabetian CP; Aasly JO; Wszolek ZK; McKeown MJ; Adam MJ; Ruth TJ; Schulzer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2018 Apr; 17(4):309-316. PubMed ID: 29456161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
    Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
    Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roco Proteins and the Parkinson's Disease-Associated LRRK2.
    Liao J; Hoang QQ
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.